RGX-202 is an oral small molecule inhibitor of SLC6A8 that induces apoptosis (cell death) of colorectal cancer cells.
RGX-104 is an oral small molecule activator of LXR/APOE that inhibits the growth of tumor blood vessels (angiogenesis) and activates tumor myeloid cells to enhance the immune response against tumors.
Science underlying Inspirna’s technology and pipeline has been published in leading scientific journals
November 17, 2022 08:00 AM Eastern Standard Time NEW YORK--(BUSINESS WIRE)--Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class small
Event: Evercore ISI Annual HealthCONx Conference Fireside Chat Time: November 29, 2022 at 4:45pm ET Webcast Link